Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.180
-0.070 (-5.60%)
At close: Oct 30, 2026, 4:00 PM EDT
1.199
+0.019 (1.64%)
After-hours: Oct 30, 2026, 7:58 PM EDT
Allogene Therapeutics Employees
As of December 31, 2025, Allogene Therapeutics had 152 total employees, including 150 full-time and 2 part-time employees. The number of employees decreased by 77 or 33.62% compared to the previous year. That makes Allogene Therapeutics the 28,770th largest employer in the world and 3,634th in the United States.
Employees
152
Change (1Y)
-77
Growth (1Y)
-33.62%
Revenue / Employee
$30,526
Profits / Employee
-$1,088,776
Market Cap
407.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 152 | -77 | -33.62% | 150 | 2 |
| Dec 31, 2024 | 229 | -4 | -1.72% | 226 | 3 |
| Dec 31, 2023 | 233 | -128 | -35.46% | 232 | 1 |
| Dec 31, 2022 | 361 | 51 | 16.45% | 359 | 2 |
| Sep 30, 2022 | 356 | 55 | 18.27% | 356 | 0 |
| Jun 30, 2022 | 344 | 59 | 20.70% | 344 | 0 |
| Mar 31, 2022 | 334 | 58 | 21.01% | 334 | 0 |
| Dec 31, 2021 | 310 | 45 | 16.98% | 308 | 2 |
| Sep 30, 2021 | 301 | 37 | 14.02% | 301 | 0 |
| Jun 30, 2021 | 285 | 49 | 20.76% | 285 | 0 |
| Mar 31, 2021 | 276 | 61 | 28.37% | 276 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| ProKidney | 231 |
| MapLight Therapeutics | 133 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
ALLO News
- 2 days ago - Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data - GlobeNewsWire
- 5 days ago - Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Allogene Therapeutics participates in a conference call with JPMorgan - TheFly
- 7 weeks ago - Allogene Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 1 month ago - Allogene Therapeutics management to meet with Piper Sandler - TheFly
- 1 month ago - Allogene Therapeutics CFO Geoffrey Parker to retire - TheFly
- 1 month ago - Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker - GlobeNewsWire
- 2 months ago - Allogene Therapeutics Announces Participation in September Investor Conference - GlobeNewsWire